Cadila provides an extensive range of products for the prevention and treatment of cardiovascular diseases (CVD). Our first-in-the-world innovation, Polycap launched in 2009 is a polypill for primary prevention of cardiovascular events and stroke; it is designed to reduce patient pill burden and to improve patient compliance. Our cardiology range also caters to hypertension which is a major contributor to premature deaths related to CVD.

Key Brands
• Polycap